> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# State Street Holds 6.6% Of PTC Therapeutics In Passive Position
- URL: https://www.bullished.co/state-street-holds-6-6-of-ptc-therapeutics-in-passive-position-730760ff/
- Published: 2026-11-10T14:12:06.000Z
- Updated: 2026-11-10T14:12:06.000Z
- Description: The holding covered 5,512,555 shares as of September 30, with State Street certifying it was not seeking to influence control.
- Author: Matteo Parrino
- Tags: SEC Filings, PTCT, Industry: Healthcare

State Street reported a [6.6% stake](https://www.sec.gov/Archives/edgar/data/0000093751/000009375126000707/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) in [PTC Therapeutics](https://www.bullished.co/tag/ptct/), which develops and sells medicines for rare disorders, in a passive ownership disclosure filed Tuesday. The holding comprised 5,512,555 common shares as of September 30, 2026, dating the position to that day rather than a purchase on the filing date.

## Ownership Without A Control Campaign

State Street certified that the holding arose from its normal business activities and that it did not acquire or hold the shares to change or influence PTC's control.

State Street had [shared voting authority](https://www.sec.gov/Archives/edgar/data/0000093751/000009375126000707/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) over 5,230,730 shares and shared authority to dispose of 5,512,555 shares. It reported no sole voting or sole disposal authority.

## PTC's Rare-Disorder Business

PTC's medicines primarily address neurological and metabolic disorders in children and adults. Its products include Sephience for phenylketonuria and Translarna and Emflaza for Duchenne muscular dystrophy.

PTC had a market value of $5.4 billion as of 9:08 a.m. ET Tuesday.

Learn

- [What a Reverse Termination Fee Means: Who Pays When a Merger Collapses →](https://www.bullished.co/learn/reverse-termination-fee-meaning/)  
A reverse termination fee is paid by the buyer to the target if a merger fails on agreed terms. See how it differs from a break-up fee, with live deal examples.
- [How To Read A Merger Proxy: A Checklist For Shareholders Facing A Vote →](https://www.bullished.co/learn/merger-proxy-statement-how-to-read/)  
Facing a merger vote? Read the proxy in this order: price and payment, vote date and threshold, board background, synergy claims, then closing conditions.

### Sources

- [SCHEDULE 13G — STATE STREET CORPORATION re: PTC THERAPEUTICS INC (PTCT)](https://www.sec.gov/Archives/edgar/data/0000093751/000009375126000707/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR

### More on PTC Therapeutics

- [PTC Therapeutics Authorizes Up To $500 Million Buyback, Calls Its Shares A 'Compelling Opportunity'](https://www.bullished.co/ptc-therapeutics-authorizes-up-to-500-million-buyback-calls-its-shares-a-compelling-46ade20f/)
- [PTC Therapeutics CEO Says Sephience Has Moved To 'Steady, Durable Growth' After Analyst Asks If Launch Is Slowing](https://www.bullished.co/ptc-therapeutics-ceo-says-sephience-has-moved-to-steady-durable-growth-after-analyst-asks-a069a277/)
- [PTC Therapeutics CEO Calls Sephience A 'Blockbuster' As Duchenne Drugs Lose Their Lift](https://www.bullished.co/ptc-therapeutics-ceo-calls-sephience-a-blockbuster-as-duchenne-drugs-lose-their-lift-1e28a2d5/)

[All PTC Therapeutics (PTCT) coverage →](https://www.bullished.co/tag/ptct/)